Why the next big hope for Alzheimer’s might not help most Black patients
The FDA last week gave full approval to what many scientists and doctors believe is the first drug to show promise of slowing the progression of Alzheimer’s disease. But while patient advocates are celebrating, critics see it as the unfortunate triumph of a flawed theory of the disease’s cause and predict the rollout of the […]
FDA approves Alzheimer’s disease treatment under clinical trial at University of Kentucky
A key antibody treatment in the fight against Alzheimer’s disease, which the University of Kentucky has been studying, just got a full green light from the U.S. Food and Drug Administration. The approval, which came out Thursday afternoon, means that many Kentuckians with mild cognitive impairment may enjoy an extension of their quality of life. […]
Kentucky House approves bill aimed at increasing Alzheimer’s awareness
FRANKFORT — The Kentucky House unanimously passed a bill aimed at spreading awareness about Alzheimer’s disease on Tuesday. The bipartisan House Bill 125 would require the Kentucky Department of Public Health to include information about Alzheimer’s in regularly published materials in health departments around the state and online. The goal, the bill states, is to […]
University of Kentucky works to understand how to prevent Alzheimer’s. You might be able to help.
FRANKFORT – Every two weeks, Jim and Sharon Jackson travel an hour from Morehead to Lexington to help scientists better understand how to treat Alzheimer’s disease. Jim is a study participant in a clinical trial called AHEAD, and the University of Kentucky is one of about 75 study sites around the country. During regular visits, […]